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ABSTRACT 
Mechanisms and consequences of DNA damage, response and apoptosis in spermatozoa 
by  
Julian Laubenthal 
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DNA-damage response; apoptosis; mother-father-newborn triad; lymphocyte; susceptibility 
 
DNA damage in spermatozoa is a crucial contributor to spontaneous abortion, severe 
genetic disease in the offspring and infertility.  The chromatin of spermatozoa is highly 
compacted, transcriptionally and translationally silent, hence lacking DNA damage response 
(DDR). DDR foci follow within seconds after a DNA double strand break (DSB) and correlate 
to an abortive topoisomerase-IIb activity during spermiogenesis.                                                                                                                   
When comparing the DSB frequencies at the two most fragile genomic loci (fragile sites 
FRA3B, FRA16D) in human and murine spermatozoa with lymphocytes, significantly 
increased DSB levels were detected in spermatozoa in both species. This corroborates that 
spermatozoa are more prone to DSBs than somatic cells. When comparing the DSB 
frequencies at FRA3B/FRA16D in spermatozoa of smokers with non-smokers, two-fold 
increases were found, probably caused by cigarette smoke components triggering abortive 
topoisomerase-IIβ activity. The phosphorylated DDR proteins H2AX and ATM were 
identified in human spermatozoa and murine spermatids using multicolour immunostaining 
with laser-scanning confocal microscopy (LSCM) and Western blots. Based on significantly 
increased DDR foci in spermatozoa of smoking men, but lacking DDR foci in response to in 
vitro challenge with H2O2, an abortive topoisomerase-IIb activity is the likely cause of DDR 
foci in spermatozoa. As DDR foci are susceptible to cigarette smoke, they can potentially be 
used as a novel biomarker. When comparing paternal spermatozoa, and lymphocytes as 
well as maternal and cord lymphocytes from 39 families for DSBs (via high-throughput 
LSCM pH2AX detection) and DNA fragmentation (Comet assay), significant increases were 
found in newborns of mothers exposed to environmental tobacco smoke and smoking 
fathers. When challenging lymphocytes and spermatozoa to different genotoxicants, 
significantly increased DNA damage in newborns compared to adults was found. This 
confirms an exceptional vulnerability in newborns, believed to cause increased susceptibly 
to disease in later life, including cancer.  
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rtPCR Real time Polymerase chain reaction 
RPMI  Roswell Park Memorial Institute  
RNA Ribonucleic acid 
ROS Reactive oxygen species 
SALF Sperm specific transcription factor 
SDS Sodium dodecyl sulfate 
SSB Single strand break 
TBS Tris buffered saline 
TCA Trichloroacetic acide 
TEMED Tetramethylethylenediamine 
Texas Red  Sulforhodamine 101 acid chloride 
TTP Thymine-5’-triphospahte 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end 
labelling 
UTP Uracil-5’-triphosphate 
WWOX WW domain containing oxidoreductase 
 
